NDC 43598-823 – Fexofenadine HCl and Pseudoephedrine HCI

Fexofenadine Hydrochloride 60 mg/1; Pseudoephedrine Hydrochloride 120 mg/1 · Tablet, Extended Release · Oral

Human Otc Drug 2 recalls

Product NDC43598-823

Product details

Brand name
Fexofenadine HCl and Pseudoephedrine HCI
Generic name
Fexofenadine HCl and Pseudoephedrine HCI
Labeler
Dr. Reddy's Laboratories Inc.
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA076667
Marketed since
July 18, 2019
Listing expires
December 31, 2026
Pharmacologic class
Histamine-1 Receptor Antagonist; alpha-Adrenergic Agonist

Active ingredients

Uses, dosage, side effects and warnings for Fexofenadine HCl and Pseudoephedrine HCI →

Package NDC codes (3)

Package NDCDescriptionSince
43598-823-144 BLISTER PACK in 1 CARTON (43598-823-14) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACKJul 18, 2019
43598-823-316 BLISTER PACK in 1 CARTON (43598-823-31) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACKJul 18, 2019
43598-823-352 BLISTER PACK in 1 CARTON (43598-823-35) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACKOct 31, 2019

Recalls mentioning this NDC

Other Fexofenadine HCl and Pseudoephedrine HCI products